Get started
Author

Ryo Morita

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
2024 · Yoko Tsukita, Takehiro Tozuka, et al. · JAMA Oncology · 79
PDF
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
2024 · Yoshimasa Shiraishi, Shogo Nomura, et al. · The Lancet Respiratory Medicine · 60
PDF
Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells
2022 · Jun Shimizu, Tadahiro Sasaki, et al. · Scientific Reports · 52
PDF
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)
2025 · Taiki Hakozaki, Kentaro Tanaka, et al. · Journal of Thoracic Oncology · 26
Dengue Virus Type 1 Infection in Traveler Returning from Tanzania to Japan, 2019
2019 · Kazuma Okada, Ryo Morita, et al. · Emerging infectious diseases · 24
PDF
COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient
2023 · Ryo Morita, Ritsuko Kubota-Koketsu, et al. · iScience · 17
PDF
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A
2024 · A. Mouri, A. Kisohara, et al. · ESMO Open · 10
PDF
Longitudinal ventilatory ratio monitoring for COVID-19: its potential in predicting severity and assessing treatment response
2021 · Natsuko Kaku, Yu Nakagama, et al. · Critical Care · 9
PDF
Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial
2026 · Amy E Colson, Princy N Kumar, et al. · The Lancet · 7
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial
2025 · Tetsuhiko Asao, Yu Saida, et al. · The Lancet Respiratory Medicine · 5
PDF
Safety and efficacy of durvalumab plus carboplatin and etoposide for patients with previously untreated extensive-stage small-cell lung cancer (ES-SCLC) with a poor performance status: The results from phase II single-arm study (NEJ045A study).
2024 · Yu Saida, Tetsuhiko Asao, et al. · Journal of Clinical Oncology · 5
An Adult Case of Unilateral Left Pulmonary Artery Agenesis Presenting with Hemoptysis
2022 · Yuriko Ishida, Masaru Suzuki, et al. · Internal Medicine · 4
PDF
Erdheim-Chester Disease Involving the Central Nervous System with Latent Toxoplasmosis
2022 · Tomoya Wadayama, Mikito Shimizu, et al. · Internal Medicine · 4
PDF
Dengue virus type 3 infection in a traveler returning from Costa Rica to Japan in 2023
2024 · Tadahiro Sasaki, Ryo Morita, et al. · Tropical Medicine and Health · 3
Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study
2022 · Yoshinobu Matsuda, Hideaki Hasuo, et al. · BMJ Supportive & Palliative Care · 3
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902
2025 · Yoko Tsukita, Rei Umezawa, et al. · JTO Clinical and Research Reports · 2
PDF
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trial
2024 · Hirotoshi Iihara, Masamichi Iwai, et al. · Lung Cancer · 2
1292MO A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ039A
2023 · R. Ko, A. Mouri, et al. · Annals of Oncology · 2
PDF
Updated analysis from NEJ045A study: Safety and efficacy of durvalumab plus carboplatin and etoposide for previously untreated extensive-stage small-cell lung cancer patients with a poor performance status.
2025 · Tetsuhiko Asao, Satoshi Watanabe, et al. · Journal of Clinical Oncology · 1
PDF
617P Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101)
2024 · H. Kikuchi, H. Mizugaki, et al. · Annals of Oncology · 1
PDF
Phase II study of combination of radiotherapy with pembrolizumab plus chemotherapy in patients with previously untreated metastatic non-small cell lung cancer: North Japan Lung Cancer Study Group 1902.
2024 · Taku Nakagawa, Yoko Tsukita, et al. · Journal of Clinical Oncology · 1
PDF
Penetration of Single-dose Levofloxacin into Intestinal Tissue
2013 · Takashi Nakajima, Yoko Kaji, et al. · Journal of Gastroenterology and Hepatology Research · 1
Antibodies against dengue virus in COVID-19 patients in Japan: a dengue virus non-endemic country
2026 · Narin Thippornchai, Ryo Morita, et al. · Tropical Medicine and Health
Development and evaluation of patient education material for splenectomy patients
2026 · Masahiko Kita, Ryo Morita, et al. · PEC Innovation
Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study
2026 · Chikashi Iwasaki, Eisaku Miyauchi, et al. · Cancer Treatment and Research Communications
PDF
Works count: 43
Citation count: 318
H-index: 8
I10-index: 7
Year
Topic
Type